ArticleParkinson's disease2026
Navigating PINK1 Parkinson's Disease: Narratives of Pacific Patients and Caregivers.
Article in Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease in its common form is a sporadic disease of older age affecting men more than women, with onset after the age of 60 years. However, Parkinson's disease, caused by variants in the PINK1 gene, affects males and females equally and causes early-onset Parkinson's disease. Furthermore, although it is rare elsewhere in the world, it is relatively common among Pacific populations, where carrier rates can reach 1 in 18 for a specific variant. All these differences between PINK1 Parkinson's disease and typical Parkinson's disease would be expected to affect people differently; however, the understanding of how this form of Parkinson's disease affects Pacific peoples is limited. Exploring the lived experiences of people with PINK1 Parkinson's disease and their caregivers is essential for informing culturally responsive care. We employed a specific Pacific qualitative research approach called Talanoa, which is centred on storytelling and open dialogue sessions, to explore the experiences of Pacific people with PINK1 Parkinson's disease and their caregivers. Data were analysed thematically. We studied 16 participants (11 patients and 5 caregivers). Two main themes were identified:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.